INDRANIBOther Agricultural Products
Indrayani Biotech Ltd — Cash Flow Statement
₹7.23
-2.77%
Indrayani Biotech Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -8.12 Cr | -46.84 Cr | -27.23 Cr | 2.90 Cr | — |
| Repayment Of Debt | -2.36 Cr | 0.00 | 0.00 | -1.37 Cr | — |
| Capital Expenditure | -1.38 Cr | -16.49 Cr | -43.41 Cr | -1.21 Cr | — |
| End Cash Position | 0.29 Cr | 0.58 Cr | 3.04 Cr | 1.50 Cr | — |
| Beginning Cash Position | 0.58 Cr | 3.04 Cr | 1.50 Cr | 0.68 Cr | — |
| Changes In Cash | -0.29 Cr | -2.45 Cr | 1.53 Cr | 0.82 Cr | — |
| Financing Cash Flow | -18.30 Cr | 44.24 Cr | 32.74 Cr | -2.73 Cr | — |
| Net Other Financing Charges | -11.87 Cr | 15.83 Cr | -7.11 Cr | -0.03 Cr | — |
| Net Issuance Payments Of Debt | -2.36 Cr | 37.23 Cr | 22.59 Cr | -1.37 Cr | — |
| Net Long Term Debt Issuance | -2.36 Cr | 37.23 Cr | 22.59 Cr | -1.37 Cr | — |
| Long Term Debt Payments | -2.36 Cr | 0.00 | 0.00 | -1.37 Cr | — |
| Investing Cash Flow | 24.74 Cr | -16.34 Cr | -47.39 Cr | -0.56 Cr | — |
| Net Other Investing Changes | 24.84 Cr | 0.07 Cr | — | — | 0.01 Cr |
| Interest Received Cfi | 0.63 Cr | 0.00 | — | — | 0.00 |
| Net Investment Purchase And Sale | -0.02 Cr | 0.00 | -0.22 Cr | — | -0.17 Cr |
| Purchase Of Investment | -0.02 Cr | 0.00 | -0.22 Cr | — | -0.17 Cr |
| Net PPE Purchase And Sale | -1.38 Cr | -16.30 Cr | -23.89 Cr | -1.19 Cr | — |
| Purchase Of PPE | -1.38 Cr | -16.30 Cr | -23.89 Cr | -1.19 Cr | — |
| Operating Cash Flow | -6.74 Cr | -30.35 Cr | 16.19 Cr | 4.11 Cr | — |
| Taxes Refund Paid | 1.16 Cr | 0.00 | 0.00 | 0.00 | — |
| Change In Working Capital | -17.84 Cr | -54.41 Cr | -5.11 Cr | -2.85 Cr | — |
| Change In Other Current Liabilities | 29.19 Cr | -0.12 Cr | 30.77 Cr | 4.59 Cr | — |
| Change In Other Current Assets | -15.10 Cr | -25.73 Cr | -28.69 Cr | -0.72 Cr | — |
| Change In Payable | -13.81 Cr | 14.65 Cr | 16.92 Cr | 2.48 Cr | — |
| Change In Inventory | 1.01 Cr | -30.14 Cr | -10.68 Cr | -0.44 Cr | — |
| Change In Receivables | -19.16 Cr | -14.04 Cr | -15.87 Cr | -9.33 Cr | — |
| Other Non Cash Items | 12.68 Cr | 9.83 Cr | 5.52 Cr | 1.86 Cr | — |
| Depreciation And Amortization | 3.37 Cr | 3.81 Cr | 3.35 Cr | 0.66 Cr | — |
| Depreciation | 3.37 Cr | 3.81 Cr | 3.35 Cr | 0.66 Cr | — |
| Net Income From Continuing Operations | -6.11 Cr | 10.42 Cr | 11.93 Cr | 4.44 Cr | — |
| Issuance Of Debt | — | 37.23 Cr | 22.59 Cr | — | 1.21 Cr |
| Issuance Of Capital Stock | — | 4.63 Cr | 23.28 Cr | — | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | 5.49 Cr | — | — | 1000.00 |
| Interest Paid Cff | — | -9.88 Cr | -5.56 Cr | -1.88 Cr | -1.96 Cr |
| Net Common Stock Issuance | — | 4.63 Cr | 23.28 Cr | — | 0.00 |
| Common Stock Issuance | — | 4.63 Cr | 23.28 Cr | — | 0.00 |
| Long Term Debt Issuance | — | 37.23 Cr | 22.59 Cr | — | 1.21 Cr |
| Net Intangibles Purchase And Sale | — | 0.00 | -19.52 Cr | -0.02 Cr | 14000.00 |
| Purchase Of Intangibles | — | 0.00 | -19.52 Cr | -0.02 Cr | 0.00 |
| Sale Of PPE | — | 0.07 Cr | — | 0.00 | 0.01 Cr |
| Capital Expenditure Reported | — | -0.19 Cr | — | — | — |
| Sale Of Intangibles | — | — | — | — | 14000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Indrayani Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.